Birdwatch Note
2023-02-25 17:00:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Context needed: His stats on acetaminophen & ibuprofen harms come from MISUSE (intentional or unintentional) of these drugs. Any vaccine adverse events we are seeing come from using them exactly as directed. https://www.fda.gov/drugs/safe-use-over-counter-pain-relievers-and-fever-reducers/using-acetaminophen-and-nonsteroidal-anti-inflammatory-drugs-safely
Written by 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1629154617639444480
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1629526655038267393
- noteId - 1629526655038267393
- participantId - 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4
- noteAuthorParticipantId -
- createdAtMillis - 1677344404356
- tweetId - 1629154617639444480
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Context needed: His stats on acetaminophen & ibuprofen harms come from MISUSE (intentional or unintentional) of these drugs. Any vaccine adverse events we are seeing come from using them exactly as directed. https://www.fda.gov/drugs/safe-use-over-counter-pain-relievers-and-fever-reducers/using-acetaminophen-and-nonsteroidal-anti-inflammatory-drugs-safely
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-02-25 17:00:04 UTC (1677344404356) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-02-26 23:27:58 -0600 | 159E77F7A49939858F70E428C351744792986C7CF9F2B051870149351425B88E | Rating Details |
| 2023-02-26 22:54:36 -0600 | 27F45B11737E318FE6CA2ACF4A5D5A318F689F7E042F97B8D1972CB378ACCD17 | Rating Details |
| 2023-02-25 18:56:49 -0600 | 294607256D75766CC2D752CDBC3A2CA5BD8CD582BFC93BFFCF413F42BCCBC0F1 | Rating Details |
| 2023-02-27 00:08:09 -0600 | 2EBF26F60F3A7E9005DA089FC61E341428510E1CA440226B1C2CB0CD463748D6 | Rating Details |
| 2023-02-25 11:55:53 -0600 | 3871C986B3C2BCF97D13633DBD3E4A728BFB2C0C9317A7E7E2E70475092E58E0 | Rating Details |
| 2023-02-27 00:08:20 -0600 | 3A2F1ADF0748E65F3E245026E636ABEDFA0FAA62A0D64F3FD8967743457AF105 | Rating Details |
| 2023-02-25 20:21:44 -0600 | 4491A5A92D3F78361F3449B590FE9BAFD08271191C45D52442E34AAD1EE8703F | Rating Details |
| 2023-02-25 15:56:42 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
| 2023-02-25 11:11:07 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
| 2023-02-26 12:41:37 -0600 | 53898DB17ECDDB8648EEF935CB6A549F98569E6619DAFF240C313863886015F6 | Rating Details |
| 2023-02-25 15:25:17 -0600 | 6417DECF5A09155FA5480C68B252942564B5EFBC32AACA990E68F801EB6ABFD4 | Rating Details |
| 2023-02-25 18:40:04 -0600 | 65109B6CBF27037A850CDCFD1D120D151FC44AA7666864FA5B40F5BF0CC87BD4 | Rating Details |
| 2023-02-27 00:20:59 -0600 | 6DDFD1980C89322930640AE6C1026CB26D4B62EA6ED17FF91676C25A5BE596D6 | Rating Details |
| 2023-02-25 22:50:02 -0600 | 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C | Rating Details |
| 2023-02-25 19:12:51 -0600 | 7D54F22CE3B73B5239B8B38D0C45AFA9777CC59E2DB07203A1CF2C8759343BE5 | Rating Details |
| 2023-02-25 14:21:35 -0600 | 7F21DB959A295247DC1E334C4CB153A6A5769C34F84754E3BA9C0E4D1BDCA558 | Rating Details |
| 2023-02-26 21:50:54 -0600 | 83FEF76206F4DC8CD9906D9FC71A16E4A82DEDD7EE9EA563D7514F3A82611DA8 | Rating Details |
| 2023-02-26 23:53:06 -0600 | 8EEB74836816E3149B6EA4E6F39D736189B150426AF4DDD0CFCC0BFF0B081BBF | Rating Details |
| 2023-02-26 23:39:25 -0600 | 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 | Rating Details |
| 2023-02-26 22:27:18 -0600 | 959C165EC37A9318F088F21ED4E7DEF09A8E4DC765A53F7F64C77595ADA32409 | Rating Details |
| 2023-02-25 13:33:38 -0600 | 9CFA1D90A0388EBA92575E9388BEF00CF76F31DBBD3343522205AFE1DC4E8F74 | Rating Details |
| 2023-03-02 10:15:23 -0600 | AE329E790D243C183BB2E27C9622B55AFC1A7657082580A50535A8F46D800BFD | Rating Details |
| 2023-02-26 22:04:11 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
| 2023-02-25 11:43:21 -0600 | BE66B211076EBFDAB2E949DDF0BF713FD3A44A0AE53F93B7044B7E152C25593E | Rating Details |
| 2023-02-25 11:42:57 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
| 2023-02-25 17:44:04 -0600 | CAA03362051988C27EED5CDB452B40225425DFFD9383E74818DE69DBAD59B39C | Rating Details |
| 2023-02-25 12:38:26 -0600 | D43A24BB9942E7B4E0094871D1D29247095EE8D68B3C3E43C0955F41B688AB73 | Rating Details |
| 2023-02-25 21:29:59 -0600 | D4F60DFACFA3AADD0967FF41856DA3CE5670EAF64F812D5F87A32D59C8B1F184 | Rating Details |
| 2023-02-26 23:27:14 -0600 | DF6798F890DCF1051D101AB47F19AD0EC2F9B12A9CD3AA1EF1384AD0BE618151 | Rating Details |
| 2023-02-27 00:19:42 -0600 | E089C89B780EBE9EDE32B381942AEE71582F0E8BE4D16F4C16753444BBF3DDE6 | Rating Details |
| 2023-02-26 07:33:43 -0600 | F5217B6927F1F482ED38592D64B62E8AF6BEB47CC565E0B683CA364BD1C65CFB | Rating Details |
| 2023-03-06 19:11:30 -0600 | F6BD995C6586D3157F1C593C9A62039E9DBC943F51F4C116DC56847DB740565A | Rating Details |
| 2023-02-26 07:33:43 -0600 | Rating Details | |
| 2023-02-25 13:33:38 -0600 | Rating Details | |
| 2023-02-25 11:42:57 -0600 | Rating Details | |
| 2023-02-26 23:53:06 -0600 | Rating Details | |
| 2023-02-25 11:11:07 -0600 | Rating Details | |
| 2023-02-26 12:41:37 -0600 | Rating Details | |
| 2023-03-02 10:15:23 -0600 | Rating Details | |
| 2023-02-25 21:29:59 -0600 | Rating Details | |
| 2023-02-25 18:56:49 -0600 | Rating Details | |
| 2023-02-27 00:19:42 -0600 | Rating Details | |
| 2023-02-26 22:04:11 -0600 | Rating Details | |
| 2023-02-25 15:56:42 -0600 | Rating Details | |
| 2023-02-25 11:55:53 -0600 | Rating Details | |
| 2023-02-27 00:08:20 -0600 | Rating Details | |
| 2023-02-25 20:21:44 -0600 | Rating Details | |
| 2023-02-25 18:40:04 -0600 | Rating Details | |
| 2023-03-06 19:11:30 -0600 | Rating Details | |
| 2023-02-26 23:27:14 -0600 | Rating Details | |
| 2023-02-25 11:43:21 -0600 | Rating Details | |
| 2023-02-27 00:08:09 -0600 | Rating Details | |
| 2023-02-25 22:50:02 -0600 | Rating Details | |
| 2023-02-25 15:25:17 -0600 | Rating Details | |
| 2023-02-26 23:27:58 -0600 | Rating Details | |
| 2023-02-25 17:44:04 -0600 | Rating Details | |
| 2023-02-25 19:12:51 -0600 | Rating Details | |
| 2023-02-26 23:39:25 -0600 | Rating Details | |
| 2023-02-25 14:21:35 -0600 | Rating Details | |
| 2023-02-26 22:54:36 -0600 | Rating Details | |
| 2023-02-25 12:38:26 -0600 | Rating Details | |
| 2023-02-26 21:50:54 -0600 | Rating Details | |
| 2023-02-26 22:27:18 -0600 | Rating Details | |
| 2023-02-27 00:20:59 -0600 | Rating Details |